임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

60건 표시 (상위 60건)

3상모집 예정· Hypertension
A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
리드: 한미약품
상세 →NCT07660796
2상모집 중· Primary Brain Tumor
Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
협력: 한미약품
상세 →NCT07688356
2상모집 중· Type 2 Diabetes Mellitus
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
리드: 한미약품
상세 →NCT07527650
3상모집 중· Type 2 Diabetes
A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
리드: 한미약품
상세 →NCT07379333
해당없음모집 중· Dyslipidemia Associated With Type II Diabetes Mellitus
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
협력: 한미약품, 유한양행
상세 →NCT07359105
2상모집 중· Advanced or Metastatic Melanoma
Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
리드: 한미약품
상세 →NCT07449754
1상모집 예정· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers
리드: 한미약품
상세 →NCT07297693
2상모집 중단 (진행 중)· Obese
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
리드: 한미약품
상세 →NCT07205900
1상모집 중· Obesity
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
리드: 한미약품
상세 →NCT07219589
1/2상모집 중· Fabry Disesase
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
리드: GC녹십자 · 협력: 한미약품
상세 →NCT06858397
4상모집 중· Coronary Artery Disease
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
협력: 한미약품, 유한양행
상세 →NCT06767345
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
상세 →NCT06724016
3상완료· Chronic Low-back Pain
A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
리드: 한미약품
상세 →NCT06595004
해당없음모집 중· Ischemic Stroke
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
협력: 한미약품
상세 →NCT06649240
1상완료· Healthy
A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
리드: 한미약품
상세 →NCT06518122
1상완료· Obesity
A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.
리드: 한미약품
상세 →NCT06481098
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
리드: 한미약품
상세 →NCT06357910
3상완료· Hypertension
A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
리드: 한미약품
상세 →NCT06174766
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers
리드: 한미약품
상세 →NCT06346184
3상완료· Hypertension
A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension
리드: 한미약품
상세 →NCT06438172
3상완료· Obesity
A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus
리드: 한미약품
상세 →NCT06174779
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
상세 →NCT06234397
4상상태 미확인· Breast Neoplasms
Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
협력: 한미약품
상세 →NCT05949333
1상완료· Healthy Volunteers
A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers
리드: 한미약품
상세 →NCT05862090
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers
리드: 한미약품
상세 →NCT05737082
4상모집 중· Coronary Artery Disease
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
협력: 대웅제약, 한미약품, 유한양행
상세 →NCT05845489
3상완료· Gastric Ulcer
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
리드: 한미약품
상세 →NCT05656092
1상완료· Healthy
A Study to Evaluate the PK, Safety and Tolerability of HCP1803.
리드: 한미약품
상세 →NCT05723549
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
리드: 한미약품
상세 →NCT05598151
1상완료· Renal Impairment
Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function
리드: 한미약품
상세 →NCT05711381
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
리드: 한미약품
상세 →NCT05548543
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
리드: 한미약품
상세 →NCT05548387
3상완료· Hypertension
A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
리드: 한미약품
상세 →NCT05450601
1상완료· Healthy
A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203
리드: 한미약품
상세 →NCT05481307
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.
리드: 한미약품
상세 →NCT05407220
3상완료· Hypertension
A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
리드: 한미약품
상세 →NCT05362110
2상모집 중단 (진행 중)· Congenital Hyperinsulinism
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
리드: 한미약품
상세 →NCT04732416
2상모집 중· Short Bowel Syndrome
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
리드: 한미약품
상세 →NCT04775706
3상완료· Hypertension
Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
리드: 한미약품
상세 →NCT05199129
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
리드: 한미약품
상세 →NCT05155995
3상완료· Gastritis
Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
리드: 한미약품
상세 →NCT05024721
1상완료· Healthy
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
리드: 한미약품
상세 →NCT05191563
1상완료· Healthy Volunteer
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
리드: 한미약품
상세 →NCT04975711
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
리드: 한미약품
상세 →NCT04946903
2상완료· Gastric Cancer
FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
리드: 한미약품
상세 →NCT04768686
1상완료· Healthy Adult Volunteer
Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers
리드: 한미약품
상세 →NCT04967014
2상완료· Hypertension
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
리드: 한미약품
상세 →NCT04959305
1상완료· Atrial Fibrillation
The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
리드: 한미약품
상세 →NCT04764201
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
리드: 한미약품
상세 →NCT04762407
3상완료· Hypertension
Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
리드: 한미약품
상세 →NCT04830449
3상완료· Hypertension
Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
리드: 한미약품
상세 →NCT04820907
2상모집 중단 (진행 중)· NASH - Nonalcoholic Steatohepatitis
Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
리드: 한미약품
상세 →NCT04505436
3상완료· Primary Hypercholesterolemia
Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
리드: 한미약품
상세 →NCT04652349
1상완료· Healthy Volunteer
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers
리드: 한미약품
상세 →NCT04324905
단계 미표기완료· Dyslipidemia
An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
리드: 한미약품
상세 →NCT05555238
1상완료· Healthy Volunteer
Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects
리드: 한미약품
상세 →NCT04204629
1상완료· Pharmacology
Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean Subjects
리드: 한미약품
상세 →NCT04076293
1상완료· Obese With Comorbidities
Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
리드: 한미약품
상세 →NCT04167553
3상조기 종료· Type 2 Diabetes Mellitus
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
협력: 한미약품
상세 →NCT03770728
2상조기 종료· NSCLC
Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
리드: 한미약품
상세 →NCT04044170

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.